Last price paid | 0.31 | |
Change | +3.33% [ +0.01 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 22.07.2024 17:20 |
Fixing | n.a. |
Settlement date | 21.02.2024 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +100.00% |
Year to date (YTD) | n.a. |
1 month | -41.18% |
3 months | +25.00% |
1 year | n.a. |
3 years | n.a. |
Issue price | 0.23 |
Underlying price on issue | 857.40 |
Premium | 0.07% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1305137833 |
Symbol | INOOVZ |
Security | 130513783 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Novo Nordisk -B-, DK0062498333 |
Underlying ISIN | DK0062498333 |
Funding level | 791.429400 |
Stop-loss level | 819.540400 |
Distance to stop-loss level | 9.84% |
Long/Short type | Long |
Subscription ratio | 50.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 19.02.2024 |
Premium | 6.57% |
Premium p.a. | n.a. |
Leverage | 5.13 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 117.570600 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
KUEHNE & NAGEL | 265.70 |
NOVARTIS N | 96.31 |
LOGITECH INT. | 80.64 |
Givaudan | 4'304.00 |
GEBERIT N | 565.00 |
Name | Price |
---|---|
Swiss Re | 106.05 |
ZURICH INSURANCE | 474.40 |
Alcon AG | 80.34 |
SWISSCOM N | 534.50 |
ROCHE GS | 279.90 |